24 Apr 2019

CMS OUTLINES NEW PRIMARY CARE PAYMENT MODELS AIMED AT GREATER SHARED RISK APRIL 22

      The U.S. Centers for Medicare & Medicaid Services has proposed changes with several new primary care payment models, including one that would shift providers to global payments. The Trump Administration says it is building on the progress made over the last two years and further the CMS priority

0
23 Apr 2019

PELVIC VEIN OBSTRUCTION: VeinCare Centers of Tennessee now implant new BD Venovo stents to open pelvis vein

  VeinCare Centers of Tennessee is one of the first clinics in the United States to implant the new BD Venovo stent in obstructed pelvic veins. The Venovo stent is the first stent designed specifically for use in treating obstruction of veins to be approved by the Food and Drug

0
22 Apr 2019

The AVLS NTNT Symposium will be June 1 in Atlanta

NTNT Symposium The NTNT Symposium will be June 1 in Atlanta. Non-thermal, non-tumescent ablation techniques have emerged as viable alternatives to more traditional options such as endovenous laser and radiofrequency ablation. Recent developments in reimbursement for these technologies make them even more appealing for clinicians treating venous disease.   The

0
22 Apr 2019

HHS TO DELIVER VALUE-BASED TRANSFORMATION IN PRIMARY CARE

The U.S. Department of Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma announced the CMS Primary Cares Initiative April 22, a new set of payment models that will transform primary care to deliver better value for patients throughout the

0
22 Apr 2019

AVLS RECEIVING RESEARCH ABSTRACTS FOR 2019 ANNUAL CONGRESS EMERGING SCIENCE PROGRAM

           The American Vein & Lymphatic Society (AVLS) is accepting research abstracts for presentation at the AVLS 2019 Annual Congress. Access to emerging science in the medical field is essential for physicians to deepen clinical competence and improve their practice. The AVLS 2019 Annual Congress Emerging

0
13 Apr 2019

BiosupportMD dietary supplements as adjuncts in venous, lymphatic care*

  BiosupportMD is a nutraceutical company created by John Chuback, MD, FACS, RPVI, RVT, RPhS, and his business partners Christopher Tichio and Alexander von Summer in 2015. The company was the brainchild of Dr. Chuback, a board certified general and cardiovascular surgeon who has been specializing in the treatment of

0
13 Apr 2019

DABRA Excimer Laser Atherectomy to be Presented in Key Events at Charing Cross International Symposium

Ra Medical Systems Inc., headquartered in Carlsbad, California, has scheduled its key DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) Excimer Laser Atherectomy events at the upcoming Charing Cross International Symposium in London April 16–18. Ra Medical is in Booth No. 509. These events include case and podium presentations and

0
10 Apr 2019

AVINGER GETS FDA OK FOR PANTHERIS SV SMALL VESSEL ATHERECTOMY DEVICE

  The U.S. Federal Drug Administration granted Aninger’s Pantheris SV small vessel image-guided atherectomy system pre-market approval in eight months. The Pantheris SV is an extension of the Redwood City, California-based company’s lumivascular image-guided atherectomy platform, which it hopes will expand the available market for its Pantheris devices by up

0
10 Apr 2019

Teleflex gets premarket OK for biomechanical MANTA Closure

  Teleflex Inc., a global provider of medical technologies for critical care and surgery, has announced that it received premarket approval from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial

0
10 Apr 2019

SPRY HEALTH KEEPS TIGHT FOCUS WITH THE LOOP SYSTEM

  The Palo Alto, California-based company has received FDA clearance for a wearable that can remotely monitor patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD), allowing the detection of early signs of deterioration before symptoms are noticeable. Spry Health’s tight focus could have significantly beneficial implications for

0